News | May 08, 2026
Sanofi India partners with NHM MP to expand NCD, rare disease services
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Approval strengthens the company’s growing international anti-infective portfolio
The 40-second film brings children to the forefront of the narrative
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
Subscribe To Our Newsletter & Stay Updated
